Glycorex Transplantation AB

Equities

GTAB B

SE0000524530

Medical Equipment, Supplies & Distribution

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
0.998 ^SEK	+9.43%		+12.13%	-24.68%

Feb. 28	Glycorex Transplantation AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 28	Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Glycorex Transplantation AB and Cardiotec Vascularis Ltda. Sign Partnership Agreement

April 28, 2022 at 11:23 am EDT

Glycorex Transplantation AB (publ) and Cardiotec Vascularis Ltda. has signed a partnership agreement under which Cardiotec will represent Glycorex in the Chilean market, offering the full range of Glycorex products to their customers.

Latest news about Glycorex Transplantation AB

Glycorex Transplantation AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
Glycorex Transplantation AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-30	CI
Glycorex Transplantation AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24	CI
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-28	CI
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-24	CI
Glycorex Transplantation AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Glycorex Transplantation AB Announces Collaboration with University Hospital in Toulouse	22-06-09	CI
Glycorex Transplantation AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-24	CI
Glycorex Transplantation AB and Cardiotec Vascularis Ltda. Sign Partnership Agreement	22-04-28	CI
Glycorex Transplantation AB (Publ.) Announces Appointment of Erik Melgaard Pedersen as Head of Sales, Effective April 1, 2022	22-03-07	CI
Glycorex Transplantation AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-23	CI
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-23	CI
Glycorex Transplantation Announces Agreement with Distributor in South Africa	22-01-17	CI
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-24	CI
Glycorex Transplantation AB Appoints Geert Nygaard as CEO	21-11-02	CI
Glycorex Transplantation AB Announces Presentation of results at the SABM 2021 Annual Meeting	21-09-24	CI
Glycorex Transplantation AB Announces Presentation of Results at the Jahrestagung DGFTI	21-09-22	CI
Glycorex Transplantation AB Announces Earnings Results for the Second Quarter and Six Months Ended June 30, 2021	21-08-25	CI
Glycorex Transplantation AB Announces Earnings Results for the First Quarter Ended March 31, 2021	21-05-19	CI
Glycorex Transplantation AB Publ Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-26	CI

Chart Glycorex Transplantation AB

Duration

Period

More charts

Company Profile

Glycorex Transplantation publ AB is a Sweden-based medical device company engaged in the research, development, production and sales of medical devices within the field of organ transplantation. The Company's main product, Glycosorb-ABO, facilitates organ transplantation between different blood types. Additionally, the Company has developed complementary product variants, such as Glycosorb-ABO A/B-kolonn, designed for different patient categories, and Glycosorb-Xeno, which can facilitate transplants between animals and humans. As of December 31, 2011, Glycosorb-ABO was used in 103 transplantation centers in 22 countries. As of December 31, 2011, the Company had four wholly owned subsidiaries, namely Glycoprobe AB, Glycorex Transplantation, Glycorex UMC AB and Glycorex UBP AB.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-22 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Medical Supplies

	1st Jan change	Capi.
GLYCOREX TRANSPLANTATION AB	-24.68%	6.14M
COLOPLAST A/S	+11.63%	27.79B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-31.67%	2.98B
WINNER MEDICAL CO., LTD.	-14.68%	2.52B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+11.64%	2.34B
HARTALEGA HOLDINGS	+2.96%	1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-11.65%	1.83B
TOP GLOVE CORPORATION BHD.	-1.67%	1.39B
NAKANISHI INC.	-0.38%	1.27B
KANGJI MEDICAL HOLDINGS LIMITED	+3.58%	1.13B

Medical Supplies